These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33671082)

  • 21. Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise.
    Giloteaux L; Glass KA; Germain A; Franconi CJ; Zhang S; Hanson MR
    J Extracell Vesicles; 2024 Jan; 13(1):e12403. PubMed ID: 38173127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS.
    Twisk FN; Maes M
    Neuro Endocrinol Lett; 2009; 30(3):284-99. PubMed ID: 19855350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two symptoms can accurately identify post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome.
    Davenport TE; Chu L; Stevens SR; Stevens J; Snell CR; Van Ness JM
    Work; 2023; 74(4):1199-1213. PubMed ID: 36938769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender-specific changes in the microRNA expression profiling in ME/CFS.
    Cheema AK; Sarria L; Bekheit M; Collado F; Almenar-Pérez E; Martín-Martínez E; Alegre J; Castro-Marrero J; Fletcher MA; Klimas NG; Oltra E; Nathanson L
    J Cell Mol Med; 2020 May; 24(10):5865-5877. PubMed ID: 32291908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
    Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Mixed Methods System for the Assessment of Post Exertional Malaise in Encephalomyelitis/Chronic Fatigue Syndrome.
    Stussman B; Calco B; Norato G; Gavin A; Chigurupati S; Nath A; Walitt B
    medRxiv; 2023 Apr; ():. PubMed ID: 37205352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G; Maes M
    Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-exertional malaise in daily life and experimental exercise models in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Vøllestad NK; Mengshoel AM
    Front Physiol; 2023; 14():1257557. PubMed ID: 38111900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome.
    Ghali A; Lacout C; Ghali M; Gury A; Beucher AB; Lozac'h P; Lavigne C; Urbanski G
    Sci Rep; 2019 Dec; 9(1):18817. PubMed ID: 31827223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in ME and CFS Symptomology in Patients with Normal and Abnormal Exercise Test Results.
    McManimen SL; Jason LA
    Int J Neurol Neurother; 2017; 4(1):. PubMed ID: 28713856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Post-exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Stussman B; Williams A; Snow J; Gavin A; Scott R; Nath A; Walitt B
    Front Neurol; 2020; 11():1025. PubMed ID: 33071931
    [No Abstract]   [Full Text] [Related]  

  • 32. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired Health-Related Quality of Life in Adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Impact of Core Symptoms.
    Roma M; Marden CL; Flaherty MAK; Jasion SE; Cranston EM; Rowe PC
    Front Pediatr; 2019; 7():26. PubMed ID: 30828572
    [No Abstract]   [Full Text] [Related]  

  • 34. [Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].
    Renz-Polster H; Scheibenbogen C
    Inn Med (Heidelb); 2022 Aug; 63(8):830-839. PubMed ID: 35925074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta.
    Nijs J; Van Oosterwijck J; Meeus M; Lambrecht L; Metzger K; Frémont M; Paul L
    J Intern Med; 2010 Apr; 267(4):418-35. PubMed ID: 20433584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    van Campen CLMC; Rowe PC; Visser FC
    Clin Neurophysiol Pract; 2021; 6():245-255. PubMed ID: 34667909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
    Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
    J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing Idiopathic Chronic Fatigue and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in Males: Response to Two-Day Cardiopulmonary Exercise Testing Protocol.
    van Campen CLMC; Visser FC
    Healthcare (Basel); 2021 Jun; 9(6):. PubMed ID: 34198946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.